These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7386475)

  • 21. Evaluation of an aseptic technique testing and challenge kit (ATTACK).
    Turco S; Miele WH; Barnoski D
    Hosp Pharm; 1993 Jan; 28(1):11-3, 16-8. PubMed ID: 10124004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Centralized intravenous admixture program for nine British hospitals.
    Tallett ER
    Am J Hosp Pharm; 1978 Feb; 35(2):163-5. PubMed ID: 626198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aseptic simulation test for cytotoxic drug production in isolators.
    Savry A; Correard F; Bennis Y; Roubaud S; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Mar; 71(6):476-81. PubMed ID: 24589539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers.
    Allinson RR; Stach PE; Sherrin TP; Latiolais CJ
    Am J Hosp Pharm; 1979 Apr; 36(4):513-7. PubMed ID: 433938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenterals laboratory course to reduce microbial contamination rates in media fill tests performed by pharmacy students.
    Isanhart CM; McCall KL; Kretschmer D; Grimes BA
    Am J Pharm Educ; 2008 Apr; 72(2):27. PubMed ID: 18483595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good compounding practice for medicaments: a proposed plan for a community pharmacy.
    Marchetti M; Riccieri FM
    Farmaco Prat; 1978 Feb; 33(2):49-62. PubMed ID: 631313
    [No Abstract]   [Full Text] [Related]  

  • 30. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C; Sautter AM; Favet J; Bonnabry P
    Am J Health Syst Pharm; 2009 Nov; 66(22):2032-6. PubMed ID: 19890087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Status of achievement of the aseptic preparation method for total parenteral nutrition expected by physicians and nurses].
    Higuchi K; Asakura M; Tsukamoto T; Morita S
    Yakugaku Zasshi; 2002 Nov; 122(11):1001-10. PubMed ID: 12440158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing of microbial contamination during the preparation of the radiocompound [⁹⁰Y]DOTATOC for clinical trials: a process validation study by Media Fill approach.
    Sirna V; Garaboldi L; Papi S; Martano L; Omodeo Salè E; Paganelli G; Chinol M
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):553-9. PubMed ID: 20927022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. I.V. admixture profiling: a simple system.
    Grabowski B; Tanner DJ
    Hosp Pharm; 1979 May; 14(5):245-6, 248, 252-4 passim. PubMed ID: 10242202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adventitious contamination of intravenous admixtures during sterility testing.
    Bernick JJ; Brown DG; Bell JE
    Am J Hosp Pharm; 1979 Nov; 36(11):1493-6. PubMed ID: 517534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premixed intravenous admixtures: a critical challenge for hospital pharmacy.
    Loeb AJ; Fishman DA; Kochis TR
    Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 37. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a device for monitoring sterility of injectable fluids.
    Mayhall CG; Pierpaoli PG; Hall GO; Thomas RB
    Am J Hosp Pharm; 1981 Aug; 38(8):1148-50. PubMed ID: 6791498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.